Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Borden Ladner Gervais LLP

02 2Janssen-Ortho Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Ceftobiprole Medocaril

Brand Name : ZEFTERA

Patent Number : 2224438

Filing Date : 1997-12-10

Strength per Unit : 500 mg / vial

Dosage Form : Sterile Lyophilized Powder for intravenous infusio

Human Or VET : Veterinary

Route of Administration : Intravenous Infusion

Patent Expiration Date : 2017-12-10

Date Granted : 2009-02-24

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Ceftobiprole Medocaril

Brand Name : ZEFTERA

Patent Number : 2334568

Filing Date : 1999-06-07

Strength per Unit : 500 mg / vial

Dosage Form : Sterile Lyophilized Powder for intravenous infusio

Human Or VET : Veterinary

Route of Administration : Intravenous Infusion

Patent Expiration Date : 2019-06-07

Date Granted : 2009-02-24

blank

03

Borden Ladner Gervais LLP

arrow
2024 ACI Convention
Not Confirmed

Borden Ladner Gervais LLP

Country
arrow
2024 ACI Convention
Not Confirmed

Ceftobiprole Medocaril

Brand Name : ZEVTERA

Patent Number : 2334568

Filing Date : 1999-06-07

Strength per Unit : 500 mg

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2019-06-07

Date Granted : 2009-02-24

blank